Empagliflozin in ESKD - A Feasibility Study
Empagliflozin in ESKD - A Feasibility Study
Active, not recruiting · NCT05687058 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Empagliflozin in ESKD - A Feasibility Study | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, heart disorder, heart failure, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-22 | NCT05687058 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Mississippi Medical Center | 35 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jackson Medicall Mall Dialysis Clinic | Jackson | United States | 1 |
| University of Mississippi Medical Center | Jackson | United States | 1 |